Health care stocks were higher pre-bell Monday, with the Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) was ahead 0.6%.
BeiGene (BGNE) shares were up more than 3% after the drug maker said its BGB-16673 has received fast-track designation from the Food and Drug Administration for the potential treatment of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Guardant Health (GH) shares were down by more than 5% after saying it has agreed to an open market sale of common shares for up to $400 million with Jefferies as the sales agent.
MIRA Pharmaceuticals (MIRA) shares rose past 37% after reporting that a pre-clinical study in rats showed that its ketamine analog, Ketamir-2, resulted in a 100% normalization of pain thresholds at the highest dose.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。